{
    "Trade/Device Name(s)": [
        "Lyphochek Tumor Marker Plus Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K082036",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011579"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "July 1, 2008",
    "Summary Letter Received Date": "July 17, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "Adrenocorticotropic Hormone (ACTH)",
        "Alpha Fetoprotein (AFP)",
        "Aldosterone",
        "Beta-2-Microglobulin (B2M)",
        "CA 15-3",
        "CA 19-9",
        "CA 27.29",
        "CA 125",
        "Calcitonin",
        "Carcinoembryonic Antigen (CEA)",
        "Ferritin",
        "hCG Beta Subunit (\u03b2-hCG)/ hCG",
        "Prostatic Acid Phosphatase (PAP)",
        "Prolactin",
        "Prostate Specific Antigen, Total (PSA)",
        "Prostate Specific Antigen, Free (Free PSA)",
        "Thyroglobulin (Tg)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Assayed quality control material"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Lyphochek Tumor Marker Plus Control as an assayed quality control serum for laboratory monitoring of tumor marker analytes.",
    "Indications for Use Summary": "Intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for listed analytes.",
    "fda_folder": "Clinical Chemistry"
}